Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings

Shanthi Mendis1, Lars H Lindholm, Simon G Anderson

  • 1Noncommunicable Diseases and Mental Health Cluster, World Health Organization, Geneva, Switzerland. mendis@who.int

Insights

A total cardiovascular risk approach, focusing on high-risk individuals, significantly cuts drug costs and optimizes healthcare spending in low- and middle-income countries compared to single risk factor management.

Area of Science:

  • Cardiovascular epidemiology
  • Health economics
  • Public health policy

Background:

  • Cardiovascular diseases (CVDs) pose a significant burden globally, particularly in low- and middle-income countries (LMICs).
  • Current CVD risk management often relies on single risk factor thresholds, potentially leading to suboptimal resource allocation and unnecessary drug treatments.

Purpose of the Study:

  • To assess the population distribution of 10-year cardiovascular risk in eight LMICs.
  • To compare the cost-effectiveness of drug treatment strategies based on total cardiovascular risk versus single risk factor cutoffs.

Main Methods:

  • A cross-sectional study involving 8,625 participants aged 40-80 years from Nigeria, Iran, China, Pakistan, Georgia, Nepal, Cuba, and Sri Lanka.
  • Utilized World Health Organization (WHO) and International Society of Hypertension risk prediction charts for risk categorization.
  • Calculated drug therapy cost estimates for three selected countries.

Main Results:

  • A substantial majority (90.0-98.9%) of the study population exhibited a 10-year cardiovascular risk below 20%.
  • Only a small fraction (0.2-4.8%) fell into high-risk categories (≥30%).
  • Implementing a total risk approach aligned with WHO guidelines demonstrated potential for significant reduction in drug costs by limiting unnecessary treatments.

Conclusions:

  • Adopting a total cardiovascular risk strategy, rather than focusing on single risk factors, can substantially reduce healthcare expenditure by optimizing drug costs.
  • This approach enables more efficient allocation of limited resources towards individuals who would benefit most from interventions.
  • Complementary population-wide measures are essential to shift the overall cardiovascular risk distribution within the population.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...